Compare FLYW & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLYW | PBH |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2021 | 2004 |
| Metric | FLYW | PBH |
|---|---|---|
| Price | $18.55 | $50.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 3 |
| Target Price | $16.21 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 2.6M | 705.1K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 450.00 | N/A |
| EPS | 0.10 | ★ 3.91 |
| Revenue | $623,025,000.00 | ★ $975,777,000.00 |
| Revenue This Year | $19.68 | N/A |
| Revenue Next Year | $15.25 | $4.31 |
| P/E Ratio | $183.30 | ★ $12.50 |
| Revenue Growth | 26.59 | ★ 36.77 |
| 52 Week Low | $10.11 | $42.62 |
| 52 Week High | $18.92 | $79.09 |
| Indicator | FLYW | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 69.87 | 57.49 |
| Support Level | $13.15 | $44.86 |
| Resistance Level | N/A | $63.56 |
| Average True Range (ATR) | 0.76 | 1.69 |
| MACD | 0.27 | 0.51 |
| Stochastic Oscillator | 88.11 | 97.05 |
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.